{"id":"W3112984291","doi":"10.1016/s1473-3099(20)30847-1","title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance","year":2020,"lang":"en","type":"review","venue":"The Lancet Infectious Diseases","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":953,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Voriconazole; Intensive care medicine; Pulmonary aspergillosis; Aspergillosis; Medicine; Aspergillus fumigatus; Immunology; Antifungal; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2031269157915949,"score_gpt":0.497484709492048,"score_spread":0.2943577937004532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}